In the ten years since its discovery to the current EPA registered formulations today, Streptomyces lydicus WYEC 108 has been the subject of research by many noted scientists from around the world. This research has ranged from foliar and root borne disease studies on hundreds of different types of plants.
To request research documents or trial data for S. lydicus WYEC 108 and/or its commercial formulations please contact our corporate office at (888) 261-4731 or feel free to e-mail us.
If you are a researcher wishing to include any of our products in your studies please contact the Natural Industries' representative from your region.
November 2, 2007 Actinovate is approved for sale in Korea.
October, 2007
Natural Industries completes construction of it brand new, state of the art production faciltiy in order to meet demands for its patented technology,
Streptomyces lydicus strain WYEC 108.
November 2, 2007 Actinovate is approved for sale in Korea.
October, 2007
Natural Industries completes construction of it brand new, state of the art production faciltiy in order to meet demands for its patented technology,
Streptomyces lydicus strain WYEC 108.
